Last reviewed · How we verify
NCT06729164
Strategic and Interactive Signing Instruction Experiment
NA trial testing Strategic and Interactive Signing Instruction in Sign Language Skills in 150 participants. Participants enrolled and being followed up; not accepting new ones.
30 July 2026
Quick facts
| Lead sponsor | The University of Tennessee, Knoxville |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 April 2025 |
| Primary completion | 30 July 2026 |
| Estimated completion | 30 July 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Strategic and Interactive Signing Instruction
- Business-As-Usual Instruction
Conditions studied
- Sign Language Skills — all drugs for Sign Language Skills →
- Teacher Practice — all drugs for Teacher Practice →
Sponsor
The University of Tennessee, Knoxville
Who can join
Adults 4 to 12, any sex, with Sign Language Skills or Teacher Practice. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This RCT study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06729164
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Strategic and Interactive Signing Instruction
Trials testing the same drug.
- NCT06722261 — Single Case Research Design: Deaf Children's Language Outcomes · NA · active not recruiting
- NCT06729177 — Single Case Research Design: Teacher Outcomes · NA · completed
- NCT06667102 — Strategic and Interactive Signing Instruction · NA · enrolling by invitation
Other recruiting trials for Sign Language Skills
Currently open trials in the same condition.
- NCT06724523 — Pre- and Post- Descriptive Data of Language Outcomes in Deaf Children · active not recruiting
Other The University of Tennessee, Knoxville trials
Trials by the same sponsor.
- NCT07207993 — Evaluating Health Outcomes of AI-Based Fitness Wearables & App Programs in Elderly With Cognitive Decline · NA · not yet recruiting
- NCT06722261 — Single Case Research Design: Deaf Children's Language Outcomes · NA · active not recruiting
- NCT07023822 — WISH, Feasibility of a Factorial Design · NA · active not recruiting
- NCT06840028 — Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Can · NA · recruiting
- NCT06774573 — Treating Young Adult Generalized Anxiety Disorder With Text-Message Delivered Cognitive Behavioral Therapy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06729164 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Tennessee, Knoxville
- Last refreshed: 24 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06729164.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing